Dale Q Rice Investment Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Dale Q Rice Investment Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$751K	Sell	3,031 -67	-2%	-$14.4K	0.41%	26
2026 Q1	$622K	Sell	3,098 -72	-2%	-$14.9K	0.47%	32
2025 Q4	$655K	Sell	3,170 -617	-16%	-$123K	0.47%	30
2025 Q3	$707K	Sell	3,787 -153	-4%	-$26.1K	0.5%	28
2025 Q2	$651K	Sell	3,940 -4,261	-52%	-$679K	0.54%	29
2025 Q1	$1.4M	Sell	8,201 -170	-2%	-$29.5K	0.72%	22
2024 Q4	$1.39M	Buy	+8,371	New	+$1.43M	0.61%	25

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Dale Q Rice Investment Management's FBT Position: Q2 2026 in Review

Dale Q Rice Investment Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.2% in Q2 2026, selling an estimated $14.4K and leaving 3,031 shares worth $751K. The position accounts for 0.41% of the portfolio, ranked #26.

Dale Q Rice Investment Management first reported a position in FBT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.4M in Q1 2025. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Dale Q Rice Investment Management held 3,031 shares of First Trust NYSE Arca Biotechnology Index Fund worth $751K as of Q2 2026.
Dale Q Rice Investment Management sold 67 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $14.4K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.41% of Dale Q Rice Investment Management's portfolio in Q2 2026, its #26 holding.
Dale Q Rice Investment Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2024 and has held it in 7 quarters since.
Dale Q Rice Investment Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.4M in Q1 2025.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Dale Q Rice Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.